Physiologic modeling of the intravenous glucose tolerance test in type 2 diabetes: A new approach to the insulin compartment

被引:15
|
作者
Ward, GM
Walters, JM
Barton, J
Alford, FP
Boston, RC
机构
[1] St Vincents Hosp, Dept Endocrinol & Diabet, Melbourne, Vic, Australia
[2] St Vincents Hosp, Univ Dept Med, Melbourne, Vic, Australia
[3] Univ Penn, New Bolton Ctr, Philadelphia, PA 19104 USA
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2001年 / 50卷 / 05期
基金
英国医学研究理事会;
关键词
D O I
10.1053/meta.2001.21029
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The minimal model of Bergman et al has been used to yield estimates of insulin sensitivity (Si) and glucose effectiveness (Sg) in type 2 diabetes by incorporating exogenous insulin protocols into the regular intravenous glucose tolerance test (IVGTT). These estimates, however, are influenced by the degree to which the dose of exogenous insulin is greater than the physiologic response to a glucose load. Moreover, most studies have related to type 2 diabetes subjects whose diabetes was relatively mild in terms of therapeutic requirements. To develop a "minimal disturbance" approach in estimating Si and Sg in type 2 diabetes, we have used a reduced glucose load (200 mg/kg) and a "physiologic" insulin infusion throughout the IVGTT in a series of 8 patients, 5 of whom were insulin-requiring. Data from this approach were analyzed using the modelling program CONSAM to apply the Bergman model, either unmodified (BMM), or incorporating an additional delay element between the plasma and "remote" insulin compartments (MMD). Application of the MMD and extension of the IVGTT from 3 to 5 hours improved successful resolution of Si and Sg from 37.5% (BMM, 3-hour IVGTT) to 100% (MMD, 5-hour IVGTT). Si was reduced in these type 2 diabetes patients compared with normal subjects (1.86 +/- 0.60 v 8.65 +/- 2.27 min(-1) . muU(-1) . mL x 10(4) P < .01). The results were validated in the type 2 diabetes group using a 2-stage euglycemic clamp ((Si)CLAMP = 2.02 +/- 0.42 min(-1) . <mu>U-1 . mL x 10(4) P > .4). Sg was not significantly reduced (2.00 +/- 0.25 type 2 diabetes v 1.55 +/- 0.26 normal min(-1) x 10(2)). Data from a group of normal nondiabetic subjects was then analyzed using the MMD, but this approach did not enhance the fit of the model compared with the BMM. This result indicates that the delay in insulin action in type 2 diabetes represents an abnormality whereby the onset of insulin action cannot be described as a single phase in the transfer of insulin from plasma to the remote compartment. It is postulated that the physiologic basis for this delayed action may relate to transcapillary endothelial transfer of insulin, this process limiting the rate of onset of insulin action. Copyright (C) 2001 by W.B. Saunders Company.
引用
收藏
页码:512 / 519
页数:8
相关论文
共 50 条
  • [1] PHYSIOLOGIC SIGNIFICANCE OF INTRAVENOUS GLUCOSE TOLERANCE TEST
    FRANCKSON, JRM
    OOMS, HA
    BELLENS, R
    CONARD, V
    BASTENIE, PA
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1962, 11 (05): : 482 - &
  • [2] THE INTRAVENOUS INSULIN TOLERANCE-TEST IN TYPE-I DIABETES
    LUCAS, KJ
    KAROUNOS, DG
    ELLIS, GJ
    MORRIS, MA
    PISETSKY, DS
    FEINGLOS, MN
    RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1986, 53 (03): : 331 - 345
  • [3] Former gestational diabetes: Mathematical modeling of intravenous glucose tolerance test for the assessment of insulin clearance and its determinants
    Morettini, Micaela
    Goebl, Christian
    Kautzky-Willer, Alexandra
    Pacini, Giovanni
    Tura, Andrea
    Burattini, Laura
    MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2020, 17 (02) : 1604 - 1615
  • [4] REDUCED SAMPLING PROTOCOLS AND THE INSULIN MODIFIED INTRAVENOUS GLUCOSE-TOLERANCE TEST IN TYPE-II DIABETES
    COATES, PA
    OLLERTON, RL
    LUZIO, SD
    ISMAIL, IS
    OWENS, DR
    DIABETOLOGIA, 1993, 36 : A129 - A129
  • [5] Insulin sensitivity in Type 2 diabetes: univariate and multivariate techniques to derive estimates of insulin sensitivity from the insulin modified intravenous glucose tolerance test (FSIGT)
    Mehring, GH
    Coates, PA
    Brunel, PC
    Luzio, SD
    Owens, DR
    COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2002, 68 (02) : 161 - 176
  • [6] THE EFFECT OF VARIOUS DISEASE STATES ON THE INTRAVENOUS GLUCOSE TOLERANCE TEST AND THE GLUCOSE INSULIN TOLERANCE TEST
    WALLER, JJ
    STRIBLING, SH
    SPURR, CL
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1954, 44 (06): : 947 - 948
  • [7] CLINICAL VALUE OF GLUCOGRAM AND A NEW APPROACH TO INTRAVENOUS GLUCOSE TOLERANCE TEST
    KAWERAU, E
    SURTEES, SJ
    ZEITSCHRIFT FUR KLINISCHE CHEMIE UND KLINISCHE BIOCHEMIE, 1966, 4 (05): : 237 - +
  • [8] Importance of early phase insulin secretion to intravenous glucose tolerance in subjects with type 2 diabetes mellitus
    Kahn, SE
    Montgomery, B
    Howell, W
    Ligueros-Saylan, M
    Hsu, CH
    Devineni, D
    McLeod, JF
    Horowitz, A
    Foley, JE
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (12): : 5824 - 5829
  • [9] A new index of insulin sensitivity obtained from the oral glucose tolerance test applicable to advanced type 2 diabetes
    Kanauchi, M
    DIABETES CARE, 2002, 25 (10) : 1891 - 1892
  • [10] First-phase insulin release during the intravenous glucose tolerance test as a risk factor for type 1 diabetes
    Chase, HP
    Cuthbertson, DD
    Dolan, LM
    Kaufman, F
    Krischer, JP
    Schatz, DA
    White, NH
    Wilson, DM
    Wolfsdorf, J
    JOURNAL OF PEDIATRICS, 2001, 138 (02): : 244 - 249